TNFRSF11B and breast carcinoma: The most recent and comparable study, among 504 breast cancer patients, observed significantly worse breast cancer-specific survival among women with relatively high serum OPG concentrations after diagnosis (above vs. below median, RR = 1.70 (1.04–2.80)) [8].